Tradestie Institutional Equity Comparison Engine
SRZN vs NBP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NBP Overall Edge
NBP Captures Institutional Edge (2โ2 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NBP (NBP) driven by superior Valuation, Growth & Margin while SRZN counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, SRZN trades at N/M Forward P/E with -485.4% operating margin (+408.6% YoY revenue) versus NBP at 2.7x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SRZN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against NBP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
NBP
SRZN N/M vs NBP 2.7x Fwd P/E
Growth & Margin Winner
NBP
Op Margin -485.4% vs 0.0% ยท YoY +408.6% vs +0.0%
Momentum & Technical Winner
SRZN
1Y +170.6% vs -81.0% ยท 52W Pos 80% vs 0%
Options & Structure Winner
SRZN
CONSOLIDATION (5th %ile IV) vs UNCLASSIFIED (N/A IV)
SRZN
NASDAQ
Surrozen, Inc. Common
Biological Products, (No Disgnostic Substances)
$32.80
+3.76% 1D
Market Cap
$603.7M
1M Return
+39.93%
1Y Return
+170.63%
Forward P/E
N/M
Unified AI Score
32.8 / 100
SELL
Tech 50.0
Fund 32.0
Flow 64.0
Mom 40.0
NBP
US Equity
NBP
Institutional Equity
$0.79
-6.66% 1D
Market Cap
$96.3M
1M Return
-37.04%
1Y Return
-80.98%
Forward P/E
2.7x
Unified AI Score
51.9 / 100
HOLD
Tech 60.0
Fund 50.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SRZN +170.63%
NBP -80.98%
Spread: +251.61 pp (SRZN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SRZN TTM Op. Margin: -485.4%
NBP TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRZN vs NBP. Trailing 12-month operating profitability (SRZN -485.4% vs NBP 0.0%) and valuation multiples (SRZN N/M vs NBP 2.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SRZN | NBP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $603.7M | $96.3M | Larger Scale | SRZN |
| Trailing P/E Ratio Valuation | N/M | 2.7x | Lower Multiple | NBP |
| Forward P/E Ratio Valuation | N/M | 2.7x | Lower Multiple | NBP |
| Revenue Growth (YoY) Growth | +408.6% | +0.0% | Higher Growth | SRZN |
| Operating Margin (TTM) Profitability | -485.4% | 0.0% | Higher Margin | NBP |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -62.8% | -59.1% | Higher ROE | NBP |
| 52-Week Range Position Momentum | 80% ($12โ$38) | 0% ($1โ$5) | Stronger Trend | SRZN |
| Beta / 30D Volatility Risk Regime | 1.21ฮฒ ยท 62% Vol | 1.66ฮฒ ยท 81% Vol | Lower Realized Risk | SRZN |
| Unified Institutional Score Composite Signal | 32.8 / 100 (SELL) | 51.9 / 100 (HOLD) | Higher Composite | NBP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SRZN vs NBP Buy Guide
SRZN
CONSOLIDATION
37d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
NBP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SRZN nor NBP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.